Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-19T06:04:14.326Z Has data issue: false hasContentIssue false
  • English
  • Français

Vancomycin—New Uses for an Old Drug

Published online by Cambridge University Press:  02 January 2015

Sandra M. Norris  and
Lynn Limon
Sandra M. Norris
Affiliation:
School of Medicine, University of Virginia, Charlottesville, Virginia
Lynn Limon
Affiliation:
Medical College of Virginia, Richmond, Virginia
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 5 , Issue 8 , August 1984 , pp. 402 - 404
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Ceraci, JE, Heilman, FR, Nichols, DR, et al: Some laboratory and clinical experiences with a new antibiotic, vancomycin. Proceedings of the Staff Meeting of the Mayo Clinic 1956;31:564–582.Google Scholar
2.Stillman, RI, Donowitz, LG, Wenzel, RP, The emergence of Staphylococcus epidermidis as a hospitalwide nosocomial bloodstream pathogen (Abstract #933), in Programs and Proceedings of the 23rd Inter-science Conference on A ntimicrobtal Agents and Chemotherapy. Las Vegas, American Society of Microbiology, 1983.Google Scholar
3.Watanakunakorn, C, The antimicrobial action of vancomycin. Rev Infect Dis 1981;3(suppl):S210–S215.CrossRefGoogle ScholarPubMed
4.Gopal, V, Bisno, AL, Silverblatt, FJ, Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA 1976;236:1604–1606.CrossRefGoogle ScholarPubMed
5.Faville, RJ Jr, Zaske, DE, Kaplan, EL, et al: Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA 1978;240:1963–1965.CrossRefGoogle ScholarPubMed
6.Sabath, LD, Wheeler, N, Laverdiere, M, et al: A new type of penicillin resistance of Staphylococcus aureus. Lancet 1977;1:443–447.CrossRefGoogle ScholarPubMed
7.Ceraci, JE, Wilson, WR, Vancomycin therapy for infective endocarditis. Rev Infect Dis 1981;3(suppl):S250–S258.Google Scholar
8.Richmond, AS, Simberkoff, MS, Schaefler, S, et al: Resistance of Staphylococcus aureus to semisynthetic penicillins and cephalothin. J Infect Dis 1977;135:108–112.CrossRefGoogle ScholarPubMed
9.Peacock, JE Jr, Marsik, FJ, Wenzel, RP, Methicillin-resistant Staphylococcus aureus: Introduction and spread within a hospital. Ann Intern Med 1980;93:526–532.CrossRefGoogle ScholarPubMed
10.Karchmer, AW, Archer, GL, Dismukes, WE, Staphylococcus epidermidis causing prosthetic valve endocarditis: Microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983;98:447–455.CrossRefGoogle ScholarPubMed
11.Jaffe, HW, Lewis, JS, Wiesner, PJ, Vancomycin-sensitive Neisseria gonorrhoeae. J Infect Dis 1981;144:198–199.CrossRefGoogle Scholar
12.Fekety, R, Antibiotic-associated Clostridium difficile colitis. Medical Grand Rounds 1983;2:148–159.Google Scholar
13.Ceraci, JE, Hermans, PE, Vancomycin. Mayo Clin Proc 1983;58:89–91.Google Scholar
14.Ceraci, JE, Wilson, WR, Vancomycin therapy for infective endocarditis. Rev Infect Dis 1981;3(suppl):S250–S258.Google Scholar
15.Watanakunakorn, C, Bakie, C, Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci. Antimicrob Agents Chemother 1973;4:120–124.CrossRefGoogle ScholarPubMed
16.Harwick, HJ, Kalmanson, GM, Guze, LB, In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci. Antimicrob Agents Chemother 1973;4:383–387.CrossRefGoogle ScholarPubMed
17.Tedesco, F, Gurwith, M, Markham, R, et al: Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 1978;1:226–228.CrossRefGoogle Scholar
18.Bryan, CS, White, WL, Safety of oral vancomycin in functionally anephric patients. Antimicrob Agents Chemother 1978;14:634–635.CrossRefGoogle ScholarPubMed
19.Blouin, RA, Bauer, LA, Miller, DD, et al: Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother 1982;21:575–580.CrossRefGoogle ScholarPubMed
20.Keighley, MRB, Burdon, DW, Arabi, Y, et al: Randomized controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhea. Br Med J 1978;2:1667–1669.CrossRefGoogle Scholar
21.Moellering, RC, Krogstad, DJ, Greenblatt, DJ, Pharmacokinetics of vancomycin in normal subjects and in patients with reduced renal function. Rev Infect Dis 1981;3(suppl):S230–S235.CrossRefGoogle ScholarPubMed
22.Hawley, HB, Gump, DW, Vancomycin therapy of bacterial meningitis. Am J Dis Child 1973;126:261–264.Google ScholarPubMed
23.Gump, DW, Vancomycin for treatment of bacterial meningitis. Rev Infect Dis 1981;3(suppl):S289–S292.CrossRefGoogle ScholarPubMed
24.Rotschafer, JC, Crossley, K, Zaske, DE, et al: Pharmacokinetics of vancomycin: Observations in 28 patients and dosage recommendations. Antimicrob Agents Chemother 1982;22:391–394.CrossRefGoogle ScholarPubMed
25.Krogstad, DJ, Moellering, RC, Greenblatt, DJ, Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol 1980;20:197–201.CrossRefGoogle ScholarPubMed
26.Moellering, RC, Krogstad, DJ, Greenblatt, DJ, Vancomycin therapy in patients with impaired renal function: A nomogram for dosage. Ann Intern Med 1981;94:343–346.CrossRefGoogle ScholarPubMed
27.Matzke, GR, McGory, RW, Halstenson, CE, et al: Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother 1984;25:433–437.CrossRefGoogle ScholarPubMed
28.Cunha, BA, Quintiliani, R, Deglin, JM, et al: Pharmacokinetics of vancomycin in anuria. Rev Infect Dis 1981;3(suppl):S269–S272.CrossRefGoogle ScholarPubMed
29.Lindholm, DD, Murray, JS, Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis. N Engl J Med 1966;274:1047–1051.CrossRefGoogle ScholarPubMed
30.Eykyn, S, Phillip, I, Evans, J, Vancomycin for staphylococcal shunt infections in patients on regular hemodialysis. Br Med J 1970;3:80–82.CrossRefGoogle Scholar
31.Nielson, HE, Sorensen, I, Hansen, HE, Peritoneal transport of vancomycin during peritoneal dialysis. Nephron 1979;24:274–277.CrossRefGoogle Scholar
32.Schaad, UB, McCracken, GH Jr, Nelson, JD, Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 1980;96:119–126.Google ScholarPubMed
33.Schaad, UB, McCracken, GH Jr, Nelson, JD, Rely. J Pediatr 1980;97:503.CrossRefGoogle Scholar
34.McHenry, MC, Gavan, TL, Vancomycin. Pediatr Clin North Am 1983;30:31–47.CrossRefGoogle ScholarPubMed
35.Alexander, MR, A review of vancomycin after 15 years of use. Drug Intell Clin Pharm 1974;8:520–525.Google Scholar
36.Newfield, P, Roizen, MF, Hazards of rapid administration of vancomycin. Ann Intern Med 1979;91:581.CrossRefGoogle ScholarPubMed
37.Borland, CDR, Farrar, WE, Reversible neutropenia from vancomycin. JAMA 1979;242:2392–2393.CrossRefGoogle ScholarPubMed
38.West, BC, Vancomycin-induced neutropenia. South Med J 1981;74:1255–1256.CrossRefGoogle ScholarPubMed
39.Lipsky, BA, Hirschmann, JV, Drug fever. JAMA 245:851–854.CrossRefGoogle Scholar
40.Dutton, AAC, Eimes, PC, Vancomycin: Report on treatment of patients with severe staphylococcal infections. Br Med J 1959;1:1144–1149.CrossRefGoogle ScholarPubMed
41.Geraci, JE, Heilman, FR, Nichols, DR, et al: Antibiotic therapy of bacterial endocarditis VII. Vancomycin for acute micrococcal endocarditis. Proceedings of the Staff Meetings of the Mayo Clinic 1958;33:172–181.Google ScholarPubMed
42.Leach, W, Ototoxicity of neomycin and other antibiotics. J Laryngol Otol 1962;76:774–790.CrossRefGoogle ScholarPubMed
43.Appel, GB, Neu, HC, The nephrotoxicity of antimicrobial agents (second of three parts). N Engl J Med 1977;296:722–728.CrossRefGoogle ScholarPubMed
44.Farber, BF, Moellering, RC, Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983;23:138–141.CrossRefGoogle ScholarPubMed
45.Wold, JS, Turnipseed, SA, Toxicity of vancomycin in laboratory animals. Rev Infect Dis 1981;3(suppl):S224–S229.CrossRefGoogle ScholarPubMed